ScholarIQanswers from OpenAlex

CAR T-cell therapy—paving the way for sensitized kidney transplant patients

PaperCitations, authors & open-access status

CAR T-cell therapy—paving the way for sensitized kidney transplant patients is a paper indexed in ScholarIQ from OpenAlex.

How many citations does CAR T-cell therapy—paving the way for sensitized kidney transplant patients have?

ScholarIQcitation count

CAR T-cell therapy—paving the way for sensitized kidney transplant patients has 19 citations in the OpenAlex counts ScholarIQ stores.

When was CAR T-cell therapy—paving the way for sensitized kidney transplant patients published?

ScholarIQyear

CAR T-cell therapy—paving the way for sensitized kidney transplant patients has 2024 year in the ScholarIQ index.

What is the open-access status of CAR T-cell therapy—paving the way for sensitized kidney transplant patients?

ScholarIQoa status

CAR T-cell therapy—paving the way for sensitized kidney transplant patients has closed oa status in the ScholarIQ index.

What is the DOI of CAR T-cell therapy—paving the way for sensitized kidney transplant patients?

ScholarIQdoi

The DOI for CAR T-cell therapy—paving the way for sensitized kidney transplant patients is on the source record.

What is the PMID of CAR T-cell therapy—paving the way for sensitized kidney transplant patients?

ScholarIQpmid

The PMID for CAR T-cell therapy—paving the way for sensitized kidney transplant patients is on the source record.

What is the OpenAlex record for CAR T-cell therapy—paving the way for sensitized kidney transplant patients?

ScholarIQopenalex

The OpenAlex for CAR T-cell therapy—paving the way for sensitized kidney transplant patients is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial